Transplant Infectious Disease

Article	Citations
Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient	95
Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant	52
	52
Cytomegalovirus‐associated pseudomembranous colitis in a kidney transplant recipient	51
Vaccine protection and how we measure it	48
	43
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?	40
Utility of microbiologic testing in surveillance bronchoscopy following lung transplantation: A retrospective cohort study	38
	35
SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin	32
Perspectives on biovigilance and transmission of infection of donor origin in deceased organ donation—The evolving scenario in the United Kingdom	30
Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient	28
Outcome of Pneumocystis pneumonia in transplant and non‐transplant HIV‐negative immunocompromised patients	27
Atypical pneumonia testing in transplant recipients	27
Successful treatment of Rhodococcus lung abscess and empyema thoracis in a heart transplant recipient	26
Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review	25
Nitazoxanide for Enterocytozoon bieneusi intestinal microsporidiosis	25
Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior tre	24
Neuroinvasive West Nile virus infection in solid organ transplant recipients	24
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review	23
Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study	23
Carbapenem‐resistant Serratia marcescens bloodstream infection in hematopoietic stem cell transplantation patients: Will it be the next challenge?	23
Research Advice for Early Career Transplant Infectious Disease Clinicians	21
Short‐term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors	21
1,3‐β‐D‐glucan testing for nocardiosis in solid organ transplant recipients	21

Pathogen‐agnostic immune biomarkers that predict infection after solid organ transplantation	21
The Journal in 2024: Reflections and Thanks for Our Reviewers	20
Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients	19
Cytomegalovirus‐Induced Arterial Intimal Fibrosis in the Kidney Transplant	19
A glimpse into my journey: Lung transplantation for COVID‐19	19
Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study	19
ChatGPT may help in counseling on strategies for safe living following solid organ transplantation	19
Surveillance for donor‐derived infections in Australia	18
Role of cytomegalovirus specific cell‐mediated immunity in the monitoring of cytomegalovirus infection among living donor liver transplantation adult recipients: A single‐center experience	18
The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research	18
Antifungal stewardship in solid‐organ transplantation: What is needed?	18
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients	18
The outcomes of Clostridioides difficile infection in inpatient liver transplant population	17
Impact of machine perfusion on transplant infectious diseases: New challenges and opportunities	17
Perspectives on donor‐derived infections from the Notify Library	17
Metagenomics in infectious disease diagnostics: Toward best‐use practices to optimize actionable results	16
Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective	16
Evaluation of Titer‐Proven Response Rates of Pediatric Hepatitis B‐Combination Vaccines in Adult Hematopoietic Cell Transplant Recipients	16
Could cell‐free DNA and host biomarkers assist in antimicrobial stewardship with organ transplant recipients?	16
The American Association of Tissue Banks tissue donor screening for Mycobacterium tuberculosis—Recommended criteria and literature review	15
Ultrasound for management of left ventricular assist device driveline infections: A single‐center experience	15
Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans	15
Cover Image	15
Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Di	14
Breakthrough COVID‐19 after SARS‐CoV‐2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy	14
Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients	14
A case of tuberculosis mimicking lung cancer in a kidney transplant recipient	14
Donor‐derived infections: The Swiss perspective	14
Into the unknown: Diagnosing mysterious brain lesions	14
Organ transplant patients, COVID‐19, and neutralizing monoclonal antibodies: The glass is half full	14
Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis	13
Trichophyton onychomycosis and deep dermatophytosis in a post‐heart transplant patient	13
Real‐world experience of tixagevimab‐cilgavimab pre‐exposure prophylaxis in orthotopic heart transplant recipients	13
The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center	13
Omicron breakthrough infection in a kidney‐transplant patient given pre‐exposition casirivimab and imdevimab monoclonal antibodies	13
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin	12
SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps	12
Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients	12
Shorter is better: The case for short antibiotic courses for common infections in solid organ transplant recipients	12
Kidney transplant from hepatitis C viremic donors into aviremic recipients and risk for post‐transplant BK and cytomegalovirus infection	12
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases	12
Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care	12
A case of severe COVID‐19 despite full vaccination with mRNA‐1273 SARS‐CoV‐2 vaccine (Moderna) in a kidney transplant recipient	11
Paradoxical outcomes of gram‐negative bloodstream infection in solid organ transplant recipients	11
Impact of human leukocyte antigen compatibility on outcomes of living donor liver transplantation: Experience from a tertiary care center	11
Use of HCV NAT+ donors: A patient's perspective	11
Donor‐derived infections: Current practice, global strategies, and future challenges	11
Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real‐life data from a multicentre retrospective study	11
Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease	11
Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial	11

Seroconversion after COVID‐19 vaccination and heart transplant recipients: Correspondence	10
The ID Digital Institute: Building a digital education toolset and community	10
Riders on the Storm	10
Cytomegalovirus reactivation and recalcitrant oral ulcers following coronavirus disease 2019 infection in a kidney transplant recipient	10
Correction to “Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial”	10
QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation	10
Bloodstream infections among intestinal and multivisceral transplant recipients	10
Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians	10
Disseminated histoplasmosis with refractory thrombocytopenia in a renal transplant patient	10
Surgical site infection due to Mycobacterium fortuitum in a lung transplant recipient	10
Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches	10
Cytomegalovirus‐driven early‐onset lymphocytosis in hematopoietic allogeneic transplant mimicking a T‐cell lymphoma progression	10
A rapid point‐of‐care polymerase chain reaction test in suspected viral respiratory tract infection after lung transplantation – A single‐center experience	9
Incidence and Timing of Epstein–Barr Virus Whole Blood DNAemia in Epstein–Barr Virus‐Mismatched Adult and Pediatric Solid Organ Transplant Recipients	9
Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center	9
Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons	9
Aspergillus spp. renal arteritis after kidney transplantation: A reappraisal	9
Previous use of statins does not improve the outcome of bloodstream infection after kidney transplantation	9
Revised nucleic acid test window periods: Applications and limitations in organ donation practice	9
Impact of immunosuppression on the immune response to SARS‐CoV‐2 infection: A mechanistic study	9
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole	9
Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis	9
Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients	9
When you need to dive in the deep end—Transplanting SARS‐CoV‐2 PCR+ recipients	9
Systematic fungal biomarker or polymerase chain reaction testing in lung transplant recipients: Retrospective analysis to optimize their use	9
Disseminated histoplasmosis with central nervous system involvement in a kidney transplant recipient	8
Donor‐derived fulminant herpes simplex virus hepatitis after liver transplantation: Two cases and review of literature	8
Hemophagocytic syndrome triggered by donor‐transmitted toxoplasmosis as a complication in same‐donor recipients of renal transplantation: Case report and review of the literature	8
The intricate interplay of immunosuppression and outcomes following Gram‐negative bloodstream infection in solid organ transplantation	8
Majocchi's granuloma in a patient with GATA2 haploinsufficiency undergoing hematopoietic stem cell transplantation	8
	8
Antibacterial prophylaxis for neutropenic and high‐risk hematology patients—Do the benefits outweigh the risk?	8
Cytomegalovirus related hospitalization costs among hematopoietic stem cell and solid organ transplant recipients treated with maribavir versus investigator‐assigned therapy: A US‐based study	8
Microsporidiosis after liver transplantation: A French nationwide retrospective study	8
Nontuberculous mycobacterial infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation	8
	8
	7
Minocycline‐induced hyperpigmentation in a patient on long‐term Nocardia suppressive treatment	7
A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy	7
“They paged me what?”: A transplant infectious disease guide to donor calls	7
Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis	7
Hepatic granulomas in a pediatric liver transplant recipient	7
Impact of Bebtelovimab Treatment Timing on COVID‐19 Outcomes in Ambulatory Solid Organ Transplant Recipients	7
Disseminated Mycobacterium abscessus secondary to adult onset immunodeficiency syndrome due to anti‐interferon gamma autoantibodies	7
The effectiveness and safety of low dose trimethoprim‐sulfamethoxazole for the treatment of pneumocystis pneumonia: A systematic review and meta‐analysis	7
Disseminated blastomycosis in a kidney transplant recipient	7
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipients	7
Poor hospitalization outcomes in patients undergoing allogeneic hematopoietic stem cell transplant with hospital acquired influenza infection	7
Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients	7
Favorable outcomes of COVID‐19 in vaccinated hematopoietic stem cell transplant recipients: A single‐center experience	7
Delayed diagnosis and treatment of secondary syphilis in pancreas–kidney transplant recipient: Need for increased awareness of sexually transmitted infections in solid organ transplantation	7
Post‐transplant lymphoproliferative disorder in pediatric liver transplant recipients: Experience from a South African transplant center	7
Road map to success: Advice for transplant infectious diseases job interviews, negotiation, and early career development	7
Prevention and management of infectious and tropical diseases in kidney transplant recipients residing in European outermost and overseas territories	7
Duration of antibiotics in kidney transplant recipients with pyelonephritis: Current practice, research gaps, and future research	7
Breakthrough SARS‐CoV‐2 infections among recipients of tixagevimab‐cilgavimab prophylaxis: A citywide real‐world effectiveness study	7
Extended‐spectrum β‐lactamase‐producing and carbapenem‐resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches	7
Bridging the Gaps in CMV Management in Transplantation: Lessons From Resource‐Limited Settings	7
	7
Organ vigilance in the Middle East: Challenges and prospects	7
Short‐course antibiotic treatment for Gram‐negative bloodstream infection in neutropenic cancer patients: Less is more	7
Risk factors and outcomes of BK viremia among deceased donor kidney transplant recipients based on donor characteristics	7
Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?	7
Longitudinal impact of COVID‐19 on lung function in lung transplant recipients: Time to stop worrying?	7
When a fungal infection is worse than a leukemia diagnosis	7
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept	6
Bacterial genotype and clinical outcomes in solid organ transplant recipients with Staphylococcus aureus bacteremia	6
Biofire pneumonia panel in lung donors: faster detection but limited pathogens	6
Re: Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis against Multidrug‐Resistant Bacteria	6
Crusted Scabies with Facial Involvement in a Patient Following Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report	6
Daptomycin‐associated pulmonary toxicity sans eosinophilia in a hematopoietic cell transplant recipient with profound leukopenia	6
Letermovir for pre‐emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation	6
Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients	6
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023	6
Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients	6
Impact of COVID‐19 on abdominal organ transplantation: A bibliometric analysis	6
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients	6
Can Quantitative Polymerase Chain Reaction in Tissue Improve Cytomegalovirus Management? Balancing Diagnostic Sensitivity and the Risk of Overtreatment	6
Pseudomonal blepharoconjunctivitis causing neutropenic sepsis after allogeneic hematopoietic cell transplantation	6
Current state of antimicrobial stewardship and organ transplantation in Saudi Arabia	6

Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation	6
Comparative analysis and trends in liver transplant hospitalizations with Clostridium difficile infections: A 10‐year national cross‐sectional study	6
Infections in patients with primary immunodeficiencies: Insight into infections in secondary immunodeficiency and transplantation	6
Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants	6
Infection evaluation in the early period after liver transplantation: A single‐center exploration	6
Social Media Savvy, It's More Than Just the #Hashtags: How the Use of Social Media in Transplant Infectious Diseases Can Impact the Field and Patients	6
Comment on: mRNA SARS‐CoV‐2 vaccination in patients after allogeneic hematopoietic cell transplantation	6
	6
	6
	6
	6
Impact of high MELD scores on CMV viremia following liver transplantation	6
Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV‐related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA	6
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre‐emptive monitoring in the era of letermovir	6
	6
Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee	6
Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With Active Left Neck Tuberculosis: A Case Report	6
Cell‐free next‐generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study	6
A case report of successful kidney transplantation from a deceased donor with terminal COVID‐19‐related lung damage: Ongoing dilemma between discarding and accepting organs in COVID‐19 era!	5
Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?	5
Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid org	5
COVID‐19 in heart transplant recipients: Outcomes according to vaccination status	5
Donor blood cultures and outcomes after lung transplantation: a single‐center report	5
Effect of Antibiotics With Anaerobic Coverage on Graft‐Versus‐Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis	5
The nuts and bolts of transplant infectious disease training	5
	5
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis	5
Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review	5
Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey	5
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances	5
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients – A retrospective matched cohort study	5
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria	5
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non‐renal solid organ transplant recipients?	5
Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual	5
Recurrent Outbreak of Carbapenem‐Resistant IMP‐1‐Producing Pseudomonas aeruginosa in Kidney Transplant Recipients: The Impact of Prolonged Patient Colonization	5
Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation – A retrospective single‐center study	5
Hemorrhage Incognito	5
Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients	5
Moving xenotransplantation from bench to bedside: Managing infectious risk	5
Blastomycosis in solid organ transplant recipients—A retrospective series from southeastern Wisconsin	5
Beta‐lactam allergies, surgical site infections, and prophylaxis in solid organ transplant recipients at a single center: A retrospective cohort study	5
Use of live viral vaccines after HCT: Still a lot to learn	5
Issue Information	5
Antimicrobial stewardship for organ donors: Importance, current practice, and challenges	5
Minding the gap: How transplant infectious disease can help close the organ donation gap	5
Potential donor characteristics and decisions made by organ procurement organization staff: Results of a discrete choice experiment	5
Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high‐risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves	5
Cefiderocol utilization in lung transplant recipients at a single center	5
Investigation of donor‐derived Strongyloides stercoralis infection in multiple solid organ transplant recipients—California, Michigan, Ohio, 2022	5
Interleukin‐18 and tumor necrosis factor‐α are elevated in solid organ transplant recipients with possible cytomegalovirus end‐organ disease	5
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch	5
Hypercalcemia associated with Pneumocystis jirovecii pneumonia in lung transplant recipients: Two case reports	5
Heart and liver transplant recipients from donor with positive SARS‐CoV‐2 RT‐PCR at time of transplantation	4
Changing the culture of blood cultures: Opportunities for diagnostic stewardship in febrile neutropenia	4
Prevalence of carbapenemase‐producing organisms among hospitalized solid organ transplant recipients, five US hospitals, 2019–2020	4
	4
Antibiotic Exposure and Risk of Allograft Rejection and Survival After Liver Transplant: An Observational Cohort Study From a Tertiary Referral Centre	4
Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis	4
Safety and efficacy of one and two booster doses of SARS‐CoV‐2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial	4
Postexposure prophylaxis after receipt of MMR vaccine prior to emergent heart transplant	4
Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct‐acting antiviral therapies	4
Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma	4
The cascade of care in testing and treatment of latent tuberculosis infection in liver transplant candidates	4
Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival	4
Management of vancomycin‐resistant Enterococci and daptomycin‐resistant Enterococci infections in liver transplant recipients in a single academic center	4
Sotrovimab administration in vaccinated and unvaccinated kidney transplant recipients with SARS‐CoV‐2 infection: Correspondence	4
Metronidazole‐induced encephalopathy after living donor liver transplantation	4
Impact of pre‐transplant bloodstream infection on clinical outcomes after heart transplantation	4
Multi‐drug resistant and rifampin‐resistant tuberculosis in transplant recipients	4
	4
Critical Insights: Severe Outcomes of Pneumocystis Pneumonia: A 10‐year Retrospective Cohort Study	4
BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathy	4
Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant	4
Issue Information	4
Transplantation and immigration: Comparing infectious complications and outcomes between foreign‐born and US‐born kidney transplant recipients in Minnesota	4
Issue Information	4
Survival after heart transplantation for Chagas cardiomyopathy using a conventional protocol: A 10‐year experience in a single center	4
Desirability of outcome ranking and quality life measurement for antimicrobial research in organ transplantation	4
Donor‐derived strongyloidiasis: The beginning of the end?	4
Issue Information	4
Impact of donor multidrug‐resistant organisms on solid organ transplant recipient outcomes	4
Transplantation of organs from SARS‐CoV‐2‐positive donors: Preliminary experience from Spain	4
Multifocal cutaneous Mycobacterium ulcerans infection in a heart transplant recipient	4
Clinical characteristics of COVID‐19 in solid organ transplant recipients following COVID‐19 vaccination: A multicenter case series	4
Addressing the Rising Burden of Carbapenemase‐Producing Enterobacterales in Liver Transplant Recipients: A Call for Enhanced Surveillance and Prevention Strategies	4
Issue Information	4
Organ donation and HIV: Awareness and willingness to be a living donor among people with HIV in Uganda	4
Deceased Donor Infectious Diseases Testing and Antimicrobial Use: Surveys of Organ Procurement Organizations and Transplant Professionals	4
Auditing tools for antimicrobial prescribing in solid organ transplant recipients: The why, the how, and an assessment of current options	4
Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship	4
A Scoping Review of Arthropod‐Borne Flavivirus Infections in Solid Organ Transplant Recipients	4
Successful Combination Therapy with Cefiderocol and Sulbactam‐Durlobactam for Donor‐Derived Carbapenem‐Resistant Acinetobacter baumannii in a Kidney Transplant Recipient	4
The black urine challenge	4
Comment on “Re‐infection with SARS‐CoV‐2 in solid‐organ transplant recipients”	4
Antimicrobial stewardship in solid organ transplant—Opportunities in the National Health Service	4